Private-Public Partnership Publication

It’s been hectic enough that I didn’t even get a chance to highlight a recent publication from the lab - the first in 5 years in which my student is not a first author! In this case, Brad Cook (Cytophage Technologies Inc) approached me about his views on transduction and phage therapy, which aligned with mine on temperate phages. The credit goes to him for getting the ball rolling, and we put together what I think is a very tidy set of arguments highlighting the common reasons people discard a phage for therapy, and whether those criteria make sense (spoilers: some do. probably). It’s open access, so check it out here!